Metabolic diversity in myxobacteria: identification of the myxalamid and the stigmatellin biosynthetic gene cluster of Stigmatella aurantiaca Sg a15 and a combined polyketide-(poly)peptide gene cluster from the epothilone producing strain Sorangium cellulosum So ce90

Author(s):  
Stefan Beyer ◽  
Brigitte Kunze ◽  
Barbara Silakowski ◽  
Rolf Müller
Gene ◽  
2000 ◽  
Vol 249 (1-2) ◽  
pp. 153-160 ◽  
Author(s):  
Bryan Julien ◽  
Sanjay Shah ◽  
Rainer Ziermann ◽  
Robert Goldman ◽  
Leonard Katz ◽  
...  

Gene ◽  
2002 ◽  
Vol 285 (1-2) ◽  
pp. 257-267 ◽  
Author(s):  
James Ligon ◽  
Steven Hill ◽  
James Beck ◽  
Ross Zirkle ◽  
István Molnár ◽  
...  

2006 ◽  
Vol 72 (12) ◽  
pp. 7485-7494 ◽  
Author(s):  
Olena Perlova ◽  
Jun Fu ◽  
Silvia Kuhlmann ◽  
Daniel Krug ◽  
A. Francis Stewart ◽  
...  

ABSTRACT Although many secondary metabolites exhibiting important pharmaceutical and agrochemical activities have been isolated from myxobacteria, most of these microorganisms remain difficult to handle genetically. To utilize their metabolic potential, heterologous expression methodologies are currently being developed. Here, the Red/ET recombination technology was used to perform all required gene cluster engineering steps in Escherichia coli prior to the transfer into the chromosome of the heterologous host. We describe the integration of the complete 57-kbp myxothiazol biosynthetic gene cluster reconstituted from two cosmids from a cosmid library of the myxobacterium Stigmatella aurantiaca DW4-3/1 into the chromosome of the thus far best-characterized myxobacterium, Myxococcus xanthus, in one step. The successful integration and expression of the myxothiazol biosynthetic genes in M. xanthus results in the production of myxothiazol in yields comparable to the natural producer strain.


Author(s):  
Joana Martins ◽  
Niina Leikoski ◽  
Matti Wahlsten ◽  
Joana Azevedo ◽  
Jorge Antunes ◽  
...  

Cyanobactins are a family of linear and cyclic peptides produced through the post-translational modification of short precursor peptides. Anacyclamides are macrocyclic cyanobactins with a highly diverse sequence that are common in the genus <i>Anabaena</i>. A mass spectrometry-based screening of potential cyanobactin producers led to the discovery of a new prenylated member of this family of compounds, anacyclamide D8P (<b>1</b>), from <i>Sphaerospermopsis</i> sp. LEGE 00249. The anacyclamide biosynthetic gene cluster (<i>acy</i>) encoding the novel macrocyclic prenylated cyanobactin, was sequenced. Heterologous expression of the acy gene cluster in <i>Escherichia</i> <i>coli</i> established the connection between genomic and mass spectrometric data. Unambiguous establishment of the type and site of prenylation required the full structural elucidation of <b>1</b> using Nuclear Magnetic Resonance (NMR), which demonstrated that a forward prenylation occurred on the tyrosine residue. Compound <b>1</b> was tested in pharmacologically or ecologically relevant biological assays and revealed moderate antimicrobial activity towards the fouling bacterium <i>Halomonas aquamarina</i> CECT 5000.<br>


Sign in / Sign up

Export Citation Format

Share Document